Trials / Completed
CompletedNCT00254566
A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)
A Phase 3B Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial To Evaluate The Efficacy and Safety Of Azithromycin SR (Microspheres Formulation) Versus Moxifloxacin For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 398 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a research drug study to compare the effects of two antibiotics for the treatment of acute exacerbation of chronic bronchitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Moxifloxacin Placebo | 1 capsule once daily for 5 days |
| DRUG | Moxifloxacin | 1 X 400mg capsule once daily for 5 days |
| OTHER | Azithromycin SR Placebo | single dose, oral. |
| DRUG | Azithromycin SR | single dose 2.0 g oral |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2005-11-16
- Last updated
- 2009-11-11
- Results posted
- 2009-09-02
Locations
34 sites across 6 countries: China, Malaysia, Philippines, Singapore, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT00254566. Inclusion in this directory is not an endorsement.